InsiderTrades

Form 4 for BCPC BALCHEM CORP

Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-21 · accession 0001140361-24-009271 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-23 2024-02-21+ BCPC Harris Theodore L COB, Pres, CEO, Dir S - Sale+OE $153.96 -64.0K 72.3K -47% -$9.86M
DM 2024-02-23 2024-02-22 BCPC Harris Theodore L COB, Pres, CEO, Dir M - OptEx $59.11 +34.4K 100.8K +52% +$2.03M
DM 2024-02-23 2024-02-22 BCPC Harris Theodore L COB, Pres, CEO, Dir M - OptEx $0.00 +34.4K 0 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-21 S D 200 $155.91 66,412 D — —
2 Common Common Stock 2024-02-21 S D 16,015 $153.75 69,279 D — — (F2) This transaction was executed in multiples sales ranging from $153.3400 to $154.2900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
3 Common Common Stock 2024-02-21 S D 10,797 $152.97 85,294 D — — (F1) This transaction was executed in multiples sales ranging from $152.3350 to $153.3200 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
4 Common Common Stock 2024-02-22 S D 5,864 $155.25 66,412 D — — (F7) This transaction was executed in multiple sales ranging from $155.0800 to $155.5700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
5 Common Common Stock 2024-02-21 S D 2,667 $154.84 66,612 D — — (F3) This transaction was executed in multiples sales ranging from $154.4700 to $155.3800 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
6 Common Common Stock 2024-02-22 M A 10,000 $54.87 76,412 D — — (F4) Exercise of fully vested non-qualified stock options.
7 Common Common Stock 2024-02-22 M A 24,350 $60.85 100,762 D — — (F4) Exercise of fully vested non-qualified stock options.
8 Common Common Stock 2024-02-22 S D 14,497 $153.56 86,265 D — — (F5) This transaction was executed in multiple sales ranging from $153.0800 to $154.0775 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
9 Common Common Stock 2024-02-22 S D 13,989 $154.66 72,276 D — — (F6) This transaction was executed in multiple sales ranging from $154.0800 to $155.0750 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
10 Derivative Stock Options (right to buy) 2024-02-22 M A 10,000 $0.00 0 D $54.87 · — to 2025-04-28 10,000 Common Stock (F8) Stock options that vested 20% on April 28, 2016, 40% on April 28, 2017, and 40% on April 28, 2018, and are exercisable.
11 Derivative Stock Options (right to buy) 2024-02-22 M A 24,350 $0.00 0 D $60.85 · — to 2026-02-23 24,350 Common Stock (F9) Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable.